BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8878385)

  • 21. Renal histology with varying FK506 blood levels.
    Gaber LW; Moore LW; Reed L; Russell W; Alloway R; Hathaway D; Shokouh-Amiri MH; Gaber AO
    Transplant Proc; 1997; 29(1-2):186. PubMed ID: 9122955
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E
    Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J; Mendez R; Pirsch JD; Jensik SC
    Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents.
    MacFarlane G; Scheller D; Ersfeld D; Jensen T; Jevans A; Wong PY; Kobayashi M
    Ther Drug Monit; 1996 Dec; 18(6):698-705. PubMed ID: 8946668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood level monitoring of FK506 on kidney transplant recipients].
    Takahara S; Takano Y; Moutabarrik A; Kameoka H; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1857-64. PubMed ID: 7504758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up.
    Pou L; Brunet M; Bilbao I; Andreu H; Andres I; Lopez R; Margarit C; Rimola A; Corbella J
    Ther Drug Monit; 1998 Dec; 20(6):602-6. PubMed ID: 9853973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proposal of FK506 optimal dosing in living related liver transplantations.
    Ueda M; Uemoto S; Inomata Y; Okajima H; Hashida T; Tanaka K; Yamaoka Y
    Transplantation; 1995 Aug; 60(3):258-64. PubMed ID: 7544035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
    Starzl TE; Todo S; Demetris AJ; Fung JJ
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S7-14. PubMed ID: 9631858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
    Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation.
    Moreno M; Manzanares C; Castellano F; Medina E; Urruzuno P; Camarena C; Manzanares J; Jara P
    Ther Drug Monit; 1998 Aug; 20(4):376-9. PubMed ID: 9712459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.
    Vincenti F; Laskow DA; Neylan JF; Mendez R; Matas AJ
    Transplantation; 1996 Jun; 61(11):1576-81. PubMed ID: 8669100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.